In this interview, recorded at the American Society of Clinical Oncology (ASCO) Annual Meeting 2026, we speak to Elizabeth Mittendorf, ASCO President and Director of Breast Surgery at Dana-Farber Cancer Institute, Boston, Massachusetts, USA, about her career immunotherapy and milestones along the way.
Key topics discussed include:
- Cancer immunotherapy: How early breast cancer vaccine research helped inform advances in immune-based treatments
- Intentional oncology teams: Why supporting every member of the care team can improve patient experiences and outcomes
- The future of cancer care: Expanding global collaboration, investing in early career investigators, and personalizing treatment to minimize toxicity
Read the latest issue of AMJ Oncology for more expert insights and highlights from ASCO 2026.
